Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...

Additional early research suggested that combining metformin and clemastine may promote remyelination, offering hope for ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...

A large study suggests taking progesterone before pregnancy — not just after conception — may help reduce the risk for ...

General anesthesia leads to better functional outcomes than conscious sedation in stroke patients with large vessel occlusion ...

A spectrum labeling system rating foods from least to most healthy can promote healthier food purchases than other ...

Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...

The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...

The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who ...

Although widely prescribed off-label to treat many types of chronic pain, experts warn of harmful side effects.